Literature DB >> 8478612

Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.

C Mohan1, S Adams, V Stanik, S K Datta.   

Abstract

Only a fraction (12%) of 268 "autoreactive" T cell clones derived from lupus-prone mice can selectively induce the production of pathogenic anti-DNA autoantibodies in vitro and accelerate the development of lupus nephritis when transferred in vivo. The CDR3 loops of T cell receptor beta chains expressed by these pathogenic T helper (Th) clones contain a recurrent motif of anionic residues suggesting that they are selected by autoantigens with cationic residues. Herein, we found that approximately 50% of these pathogenic Th clones were specific for nucleosomal antigens, but none of them responded to cationic idiopeptides shared by variable regions of pathogenic anti-DNA autoantibodies. Nucleosomes did not stimulate the T cells as a nonspecific mitogen or superantigen. Only the pathogenic Th cells of lupus responded to nucleosomal antigens that were processed and presented via the major histocompatibility class II pathway. Although the presentation of purified mononucleosomes to the Th clones could be blocked by inhibitors of endosomal proteases, neither of the two components of the nucleosomes--free DNA or histones by themselves--could stimulate the Th clones. Thus critical peptide epitopes for the Th cells were probably protected during uptake and processing of the nucleosome particle as a whole. The nucleosome-specific Th clones preferentially augmented the production of IgG autoantibodies to histone-DNA complex in vitro. In vivo, nucleosome-specific, CD4+ T cells were not detectable in normal mice, but they were found in the spleens of lupus-prone mice as early as 1 mo of age, long before other autoimmune manifestations. Immunization of young, preautoimmune lupus mice with nucleosomes augmented the production of autoantibodies and markedly accelerated the development of severe glomerulonephritis. Previously, crude preparations containing nucleosomes were shown by others to have polyclonal mitogenic activity for B cells from normal as well as lupus mice. Identification here of pure mononucleosome as a lupus-specific immunogen for the Th cells that selectively help the pathogenic anti-DNA autoantibody producing B cells of lupus could lead to the design of specific therapy against this pathogenic autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478612      PMCID: PMC2191002          DOI: 10.1084/jem.177.5.1367

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  70 in total

1.  Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition.

Authors:  J Kaye; N J Vasquez; S M Hedrick
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

Review 2.  The role of somatic mutation in the pathogenic anti-DNA response.

Authors:  B Diamond; J B Katz; E Paul; C Aranow; D Lustgarten; M D Scharff
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

3.  A new procedure for purifying histone pairs H2A + H2B and H3 + H4 from chromatin using hydroxylapatite.

Authors:  R H Simon; G Felsenfeld
Journal:  Nucleic Acids Res       Date:  1979-02       Impact factor: 16.971

4.  Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production.

Authors:  S H Hefeneider; K A Cornell; L E Brown; A C Bakke; S L McCoy; R M Bennett
Journal:  Clin Immunol Immunopathol       Date:  1992-06

5.  Cationic residues in pathogenic anti-DNA autoantibodies arise by mutations of a germ-line gene that belongs to a large VH gene subfamily.

Authors:  T L O'Keefe; S K Datta; T Imanishi-Kari
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

6.  Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA.

Authors:  M J Losman; T M Fasy; K E Novick; M Monestier
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

7.  Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.

Authors:  D Valmori; A Pessi; E Bianchi; G Corradin
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

8.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  Pathogenesis of the glomerulonephritis of NZB/W mice.

Authors:  P H Lambert; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  175 in total

Review 1.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

2.  Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.

Authors:  Anthony D Foster; Mark Haas; Irina Puliaeva; Kateryna Soloviova; Roman Puliaev; Charles S Via
Journal:  Clin Immunol       Date:  2010-05-06       Impact factor: 3.969

3.  Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.

Authors:  Defu Zeng; Yinping Liu; Stephane Sidobre; Mitchell Kronenberg; Samuel Strober
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

4.  Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance.

Authors:  Brian W Busser; Brigette S Adair; Jan Erikson; Terri M Laufer
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

5.  Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.

Authors:  R Cervera; O Viñas; M Ramos-Casals; J Font; M García-Carrasco; A Sisó; F Ramírez; Y Machuca; J Vives; M Ingelmo; R W Burlingame
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 6.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

7.  Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.

Authors:  Shweta Jain; Jerrold M Ward; Dong-Mi Shin; Hongsheng Wang; Zohreh Naghashfar; Alexander L Kovalchuk; Herbert C Morse
Journal:  Am J Pathol       Date:  2017-07-17       Impact factor: 4.307

8.  An Lck-cre transgene accelerates autoantibody production and lupus development in (NZB × NZW)F1 mice.

Authors:  R K Nelson; K A Gould
Journal:  Lupus       Date:  2015-09-18       Impact factor: 2.911

9.  Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.

Authors:  M Satoh; A Kumar; Y S Kanwar; W H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.

Authors:  Li Zhang; Anne M Bertucci; Rosalind Ramsey-Goldman; Elizabeth Randall Harsha-Strong; Richard K Burt; Syamal K Datta
Journal:  Clin Immunol       Date:  2013-08-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.